[60]Fullerene for Medicinal Purposes, A Purity Criterion towards Regulatory Considerations

Since the early nineties countless publications have reported promising medicinal applications for [60]fullerene (C(60)) related to its unparalleled affinity towards free radicals. Yet, until now no officially approved C(60)-based drug has reached the market, notably because of the alleged dangers o...

Descripción completa

Detalles Bibliográficos
Autores principales: Keykhosravi, Sanaz, Rietveld, Ivo B., Couto, Diana, Tamarit, Josep Lluis, Barrio, Maria, Céolin, René, Moussa, Fathi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719231/
https://www.ncbi.nlm.nih.gov/pubmed/31408977
http://dx.doi.org/10.3390/ma12162571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719231/
https://www.ncbi.nlm.nih.gov/pubmed/31408977
http://dx.doi.org/10.3390/ma12162571

Ejemplares similares